Prosecution Insights
Last updated: October 02, 2026
Application No. 18/265,430

PRODUCTION OF POLYURETHANE FOAM

Non-Final OA §112
Filed
Jun 05, 2023
Priority
Dec 08, 2020 — EU 20212361.8 +1 more
Examiner
RIOJA, MELISSA A
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Evonik Operations GmbH
OA Round
3 (Non-Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
432 granted / 873 resolved
-15.5% vs TC avg
Strong +54% interview lift
Without
With
+53.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
62 currently pending
Career history
930
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
42.8%
+2.8% vs TC avg
§102
13.1%
-26.9% vs TC avg
§112
32.3%
-7.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 873 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on May 27, 2026 has been entered. Claim Objections Claims 36, 41 – 43, and 47 – 50 are objected to because of the following informalities: the second recitation of the phrase “d = 2 to 80” in Claim 36 should be deleted; it is suggested Claims 41 – 43 be amended to recite the polyester-polysiloxane block copolymers are provided; it is suggested Claim 47 be amended to recite “wherein at least one R2 radical corresponds to R4.”; and it is suggested Claims 48 – 50 be amended to recite “10% by weight of the composition”. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 36 – 51 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention because: Claim 36 now sets forth “wherein at least two different R7 radicals are present in the polyester radical of Formula 2, the polyester repeat units comprising a caprolactone residue and a residue of lactide, butyrolactone, valerolactone, or propiolactone”. These limitations conflict in scope with the earlier recited limitations that R3 and R7 are identical or different radicals, as all R3 and R7 radical cannot all be identical radicals and satisfy the aforementioned new limitation set forth. These new limitations also conflict in scope with the earlier recited limitation that R3 is at least one radical, as at least two R3 radicals now must necessarily be present. There is also a lack of antecedent basis for “the” polyester repeat units set forth, as it is unclear which polyester radicals are being referred to by this phrase. It is further unclear how at least two different R7 radicals are present in the polyester radical of Formula 2. For the purposes of examination, Claim 36 will be interpreted as setting forth “R3 = twos R3 must have the structure of Formula 2…R7 = 7 radicals are provided, such that at least one radical R3 comprises a caprolactone residue and at least one radical R3 comprises a residue of lactide, butyrolactone, valerolactone, or propiolactone.” Claim 36 sets forth R10 = identical or different alkyl radicals having 1 to 16 carbon atoms. There is a lack of antecedent basis for R10 in this phrase, as the claim does not set forth an R10 moiety prior to this recitation. For the purposes of examination, the aforementioned phrase will be interpreted as not further limiting the claim. Claim 36 now requires the presence of a caprolactone residue and a residue of lactide, butyrolactone, valerolactone, or propiolactone in polyester radicals R3. It is then unclear how the limitations set forth in Claim 37 with respect to R5, R6, and R7 in the polyester radicals now integrate with the required presence of the aforementioned residues. Additionally, Claim 37 sets forth definitions for R9 and “e”. There is a lack of antecedent basis for R9 and “e”, as the claims do not set forth R9 or “e” prior these recitations. For the purposes of examination, Claim 37 will be interpreted as only setting forth definitions for R2, a, b, and c. The metes and bounds of Claims 41 – 43 are not clearly defined. The claims set forth “parts” but do not specify how these parts are measured. For the purposes of further examination, Claims 41 – 43 will be interpreted as setting forth parts by weight in each instance. There is a lack of antecedent basis for “the” polyester repeat units of Formula 2 in Claim 51. The claims do not previously set forth the units of Formula 2 are repeat units. For the purposes of further examination, Claim 51 will be interpreted as simply setting forth the at least two radicals R3 of Formula 2. As all other pending claims ultimately depend on at least Claim 36, they incorporate the subject matter thereof and are also therefore rejected under this statute. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 38 – 40 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 36 now requires the presence of a caprolactone residue and a residue of lactide, butyrolactone, valerolactone, or propiolactone in polyester radicals R3, corresponding to polyester-polysiloxane copolymers prepared from at least two specific cyclic ester compounds. Claims 38 – 40 does not then appear include all limitations of Claim 36. Claim 38 sets forth the polyester-polysiloxane copolymers are obtained by reacting one or more cyclic esters, cyclic dimer, or higher analogues thereof. Claim 39 requires at least two or more different cyclic esters be provided but not the specifically claimed cyclic ester compounds. Claim 40 sets forth the same species of cyclic ester compound set forth in Claim 40 but only requires the presence of one of these species. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Allowable Subject Matter Claims 36, 37, and 41 – 51 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: the prior art does not teach or suggest a composition of producing polyurethane foam comprising all of the instantly claimed ingredients, including polyester-polysiloxane block copolymers of Formula 1 in which at least two different R7 radicals are provided, such that at least one radical R3 comprises a caprolactone residue and at least one radical R3 comprises a residue of lactide, butyrolactone, valerolactone, or propiolactone. US 3,778,348 to Morehouse corresponds to the closest prior art. Morehouse teaches a composition for producing a foamed polyurethane material (Column 2, Lines 1 – 4). The composition comprises an organic polyisocyanate, a polyol, a blowing agent mixture, a catalyst, and a polyester siloxane block copolymer as a surfactant (Column 13, Lines 51 – 69). In Example 4, Morehouse teaches a polyester siloxane block copolymer having the instantly claimed formula which comprises R7 radicals corresponding to caprolactone residues and R8 as an acetoxy group. The exemplary surfactant of Morehouse differs from the instant claims in that it does not further comprises an R7 radical comprising a residue of lactide, butyrolactone, valerolactone, or propiolactone and R8 is acetoxy group instead of hydrogen. While Morehouse does suggest hydrogen may be provided as a terminal group in the general disclosure, the focus of Morehouse is on the preparation of polycaprolactone siloxanes. Thus, the reference provides no guidance to partially substitute the caprolactone residues with a residue of lactide, butyrolactone, valerolactone, and/or propiolactone. Nor does any other reference provide the necessary teaching or guidance which lead a person of ordinary skill in the art to make such as substitution to the exemplary surfactant of Morehouse. The prior art thus neither anticipates nor renders obvious the claimed invention. Response to Arguments Applicant's arguments filed May 27, 2026 have been fully considered and are found persuasive. The Office agrees that the present amendments to claims are sufficient to overcome the outstanding claim objections and rejections under 35 U.S.C. 112(b) and 103. However, the amendments do raise new issues which are detailed under the corresponding claim objections and rejections under 35 U.S.C. 112(b) and (d). Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to MELISSA RIOJA whose telephone number is (571)270-3305. The examiner can normally be reached Monday - Friday 10:00 am - 6:30 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuther can be reached at (571)270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MELISSA A RIOJA/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Jun 05, 2023
Application Filed
Dec 22, 2025
Non-Final Rejection mailed — §112
Mar 16, 2026
Response Filed
Apr 07, 2026
Final Rejection mailed — §112
May 27, 2026
Request for Continued Examination
May 31, 2026
Response after Non-Final Action
Sep 15, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747333
BIODEGRADABLE COMPOSITIONS AND ARTICLES MADE FROM CELLULOSE ACETATE
4y 2m to grant Granted Sep 29, 2026
Patent 12747330
FOAMABLE SILICONE COMPOSITION
3y 9m to grant Granted Sep 29, 2026
Patent 12742034
POLYOL PREMIXES, THERMALLY INSULATING RIGID POLYURETHANE FOAMS AND METHODS FOR THEIR PRODUCTION
3y 3m to grant Granted Sep 22, 2026
Patent 12735355
METHOD FOR PREPARING GROUTING REINFORCEMENT FILLER FOR MINING
3y 6m to grant Granted Sep 15, 2026
Patent 12735554
Heat Resistant Aerogel Materials
2y 11m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+53.8%)
3y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 873 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month